Reality
There has been lots of dialogue on ADCOM and results. Lots of people feel we were railroaded, ADCOM should have been approved, but unfortunately they didn't because the TST team was not prepared enough to support the trial, data and take on the panel to convince them to approve.
That is the sad reality of our situation. Face it we fk'd up, we trusted TST management and now we have to trust them to fix it. I have concerns that they will. There response has been the standard we are disappointed in the decision and we will work with FDA going forward. They need to do better than that.
Bottom line this is all about share price, thats why everyone is here. No one really cares whether MCNA can help cancer paitents, its all about money and share price, thats why we bought the stock. No one wants to lose their investment.
All the arguments people are making are good, however those comments and dialogue need to come from TST in the form of patients, family doctors, urologists, etc. TST needs to convince the FDA to move forward with approval of MCNA because they have a drug that works and can help people. That is what matters.
Otherwise we are doomed to fail, which so far appears on the horizon. Hope I am wrong.